BIDU vs GALT · rev $18.46B vs $142.4M cap
Baidu Inc (BIDU) versus Galectin Therapeutics Inc (GALT) — a side-by-side from cached financials, not a winner call.
Baidu Inc (BIDU) is a internet content & information company listed on US.
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Latest reported BIDU revenue for 2025-12-31 was $18.46B. Net income was $799.0M. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. BIDU currently screens at market cap $37.98B.
GALT does not have a complete income-statement cache yet.
BIDU currently screens at market cap $37.98B. GALT currently screens at market cap $142.4M.
Not investment advice. Open the BIDU and GALT stock pages for the full models.
Not investment advice.